Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modeling HIV risk.

D C Bell1, R A Trevino

  • 1Affiliated Systems Corporation, Houston, Texas, USA. dbell@affiliatedsystems.com

Journal of Acquired Immune Deficiency Syndromes (1999)
|April 19, 2000
PubMed
Summary
This summary is machine-generated.

This study developed an HIV risk index to estimate risks for specific populations. African-American gay male injectors faced the highest projected risk, while white heterosexual non-injectors faced the lowest.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence of striped electronic phases in a structurally modulated superlattice.

Nature·2024
Same author

Clean 2D superconductivity in a bulk van der Waals superlattice.

Science (New York, N.Y.)·2020
Same author

New approaches to nanoparticle sample fabrication for atom probe tomography.

Ultramicroscopy·2015
Same author

Epitaxial Catalyst-Free Growth of InN Nanorods on c-Plane Sapphire.

Nanoscale research letters·2010
Same author

Precision cutting and patterning of graphene with helium ions.

Nanotechnology·2009
Same author

Drug use, travel and HIV risk.

AIDS care·2002
Same journal

HIV seroprevalence, incidence, and viral suppression among Ugandan female bar workers: a population-based study.

Journal of acquired immune deficiency syndromes (1999)·2026
Same journal

Evaluating Associations Between Cumulative Use of Chronic Liver Injury-Inducing Antiretroviral Therapy and Hepatocellular Carcinoma, By Chronic Liver Disease Status.

Journal of acquired immune deficiency syndromes (1999)·2026
Same journal

Men's preferences for HIV self-test distribution strategies in Uganda: A discrete choice experiment.

Journal of acquired immune deficiency syndromes (1999)·2026
Same journal

Preferences for HIV testing among partners of transgender women in Lima, Peru: a discrete choice experiment.

Journal of acquired immune deficiency syndromes (1999)·2026
Same journal

Trends in sexually transmitted infections by PrEP use among cisgender men who have sex with men in New York City, 2014-2023.

Journal of acquired immune deficiency syndromes (1999)·2026
Same journal

Birth and Infant Growth Outcomes Following Prenatal Exposure to Bictegravir.

Journal of acquired immune deficiency syndromes (1999)·2026
See all related articles

Area of Science:

  • Epidemiology
  • Public Health
  • Biostatistics

Background:

  • Accurate Human Immunodeficiency Virus (HIV) risk assessment is crucial for targeted public health interventions.
  • Existing methods may not adequately capture granular risk variations within diverse populations.

Purpose of the Study:

  • To develop and apply an HIV risk index for estimating risk in specific local population subgroups.
  • To combine behavioral data, prevalence rates, and transmission probabilities for a comprehensive risk assessment.

Main Methods:

  • A sample of 270 individuals reported sexual and injection risk behaviors and partners in the past 30 days.
  • An HIV risk index was computed using individual risk behaviors, estimated partner HIV prevalence, and transmission probabilities.
  • Partner prevalence data were sourced from national samples, and transmission probabilities from published literature.

Related Experiment Videos

Main Results:

  • Significant variations in projected HIV risk were observed across demographic categories.
  • African-American male gay injectors exhibited the highest estimated 10-year risk (72%).
  • White male heterosexual non-injectors showed the lowest estimated 10-year risk (<0.01%).

Conclusions:

  • The developed HIV risk index is adaptable for various population subgroups and individuals.
  • Identifying high-risk subpopulations enables more precise targeting of interventions and public health campaigns.
  • This methodology enhances the efficiency and effectiveness of HIV prevention strategies.